IPP Bureau
Indian pharma resilient to US tariffs; Eyes US pricing reform gains: Ind-Ra
By IPP Bureau - August 27, 2025
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
GST rejig may impact competitiveness of medical devices: AiMeD
By IPP Bureau - August 27, 2025
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
SMS Pharmaceuticals receives EIR from USFDA for Central Laboratory Analytical Services
By IPP Bureau - August 27, 2025
The inspection, conducted from June 23 to June 25, 2025, concluded with zero Form 483 observations
India showcases herbal GMP leadership at WHO-SEARO regional workshop in Mumbai
By IPP Bureau - August 26, 2025
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
Bristol Myers Squibb to present new cardiovascular data at ESC Congress 2025
By IPP Bureau - August 26, 2025
Merck presents new data on cardiovascular disease at ESC Congress 2025
By IPP Bureau - August 26, 2025
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Remedium Lifecare charts 4X growth strategy
By IPP Bureau - August 26, 2025
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
By IPP Bureau - August 26, 2025
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Giant antibody in humans acts like a brace against bacterial toxins
By IPP Bureau - August 26, 2025
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
India releases first-ever National Guidelines/SOPs for animal blood transfusion and blood banks
By IPP Bureau - August 26, 2025
Guidelines aim to establish state-regulated veterinary blood banks
Terumo India launches Terufusion advanced infusion systems in India
By IPP Bureau - August 26, 2025
Terufusion Advanced Infusion Systems combine a smart syringe pump, smart infusion pump, and pump monitoring system software for precise and efficient drug administration
Eris Lifesciences receives ANVISA approval for sterile injectable facility
By IPP Bureau - August 26, 2025
Gland Pharma receives FDA approval for Vasopressin in 5% Dextrose RTU Injection
By IPP Bureau - August 26, 2025
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and 20 Units per 100 mL of PH Health Limited
Dr. Reddy's launches novel drug for chronic constipation management
By IPP Bureau - August 26, 2025
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
